Multiply Labs
Physical AI for biological manufacturing
Multiply Labs builds robotic biomanufacturing infrastructure that automates the full biologics manufacturing stack within closed, GMP-ready systems. Their robotic clusters integrate with a facility's existing validated instruments, enabling up to 100x throughput increases and 74% cost reductions. The platform includes real-time sensor monitoring and 21 CFR Part 11-compliant electronic records integrated with existing quality systems.
Robotic clusters connect to a facility's existing GMP instruments in a closed, sterile environment and use imitation learning and parallel orchestration to automate every unit operation, collecting real-time data and delivering electronic records to quality systems.
Pharmaceutical and biotech manufacturers producing advanced therapies and biologics
Background.
- Status
- launched
- Business model
- unknown
- Company
- Multiply Labs
Founders
- Alice Melocchi
- Fred Parietti
Similar projects.
Editorial take on the space this project sits in — momentum signals, adjacent moves, our call on whether the wedge is real. Get pinged when we publish a new read or when the landscape shifts.
Have a take on this space?
Tell us what you’d build differently, where you think the incumbents miss, or what we’ve gotten wrong about this project. Comments + reactions are coming soon.